Sfoglia per AUTORE
BERRUTI A
Collezione AOU San Luigi di Orbassano

  

Items : 140

Response to letter to the editor on "Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma". in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2025 Mar 11;218:115277. doi: 10.1016/j.ejca.2025.115277. Epub 2025 Feb 1.
2025
AOU San Luigi di Orbassano

Scatolini M; Grisanti S; Puglisi S; Tomaiuolo P; Berruti A; Terzolo M;

Germline NGS targeted analysis in adult patients with sporadic adrenocortical carcinoma. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2024 Jul;205:114088. doi: 10.1016/j.ejca.2024.114088. Epub 2024 Apr 26.
2024
AOU San Luigi di Orbassano

Scatolini M; Grisanti S; Tomaiuolo P; Grosso E; Basile V; Cosentini D; Puglisi S; Laganà M; Perotti P; Saba L; Rossini E; Palermo F; Sigala S; Volante M; Berruti A; Terzolo M;

Optimising Radioligand Therapy for Patients with Gastro-Entero-Pancreatic Neuroendocrine Tumours: Expert Opinion from an Italian Multidisciplinary Group. in Advances in therapy / Adv Ther. 2024 Jan;41(1):113-129. doi: 10.1007/s12325-023-02714-8. Epub 2023 Nov 21.
2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Stasi M; Volante M; Seregni E; Santimaria M; Schillaci O; Panzuto F; Milione M; Grimaldi F; Giordano A; D'Onofrio M; Ferone D; Bartolomei M; Berruti A; Foglia E; Falconi M; Fazio N; Lastoria S; Fazio N; Falconi M; Foglia E; Bartolomei M; Berruti A; D'Onofrio M; Ferone D; Giordano A; Grimaldi F; Milione M; Panzuto F; Santimaria M; et alii...

Corrigendum to "Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up": [Annals of Oncology volume 31 (2020) 1476-1490]. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2023 Jul;34(7):631. doi: 10.1016/j.annonc.2022.12.006. Epub 2022 Dec 21.
2023
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A; Fassnacht M; Assie G; Baudin E; Eisenhofer G; Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1-2, 2021. in Endocrine / Endocrine. 2022 Sep;77(3):409-410. doi: 10.1007/s12020-022-03147-z.
2022
AOU San Luigi di Orbassano

Berruti A; Terzolo M; Filetti S;

Progression of Vertebral Fractures in Patients with Adrenocortical Carcinoma Undergoing Mitotane Therapy. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2167-e2176. doi: 10.1210/clinem/dgab899.
2022
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Hadoux J; Libè R; Frigerio M; Laganà M; Deschamps F; Zamparini M; Lamartina L; Pedersini R; Valsecchi C; Maroldi R; Al Ghuzlan A; Terzolo M; Gasparotti R; Baudin E; Berruti A;

Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma. in ESMO open / ESMO Open. 2022 Apr;7(2):100422. doi: 10.1016/j.esmoop.2022.100422. Epub 2022 Mar 7.
2022
AOU San Luigi di Orbassano

Laganà M; Grisanti S; Ambrosini R; Cosentini D; Abate A; Zamparini M; Ferrari VD; Gianoncelli A; Turla A; Canu L; Terzolo M; Tiberio GAM; Sigala S; Berruti A;

2021
ASL Asti
AO Cuneo
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Berruti A; Tucci M; Gennari A; Baier S; Bellissimo AR; Ciccone G; Montagnani F; Comandone A; Chiappino I; Dal Canton O; Masini C; Sacco C; Zamparini M; Sirotova Z; Fea E; Valcamonico F; Vanella P; Ortega C; Buttigliero C; Prati V; Bianchi S; Mosca A; Dalla Volta A; Amoroso D;

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study. in British journal of cancer / Br J Cancer. 2021 Oct;125(9):1233-1238. doi: 10.1038/s41416-021-01513-8. Epub 2021 Aug 16.
2021
AOU San Luigi di Orbassano

Kimpel O; Bedrose S; Megerle F; Berruti A; Terzolo M; Kroiss M; Mai K; Dekkers OM; Habra MA; Fassnacht M;

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study. in European journal of endocrinology / Eur J Endocrinol. 2021 Nov 30;186(1):25-36. doi: 10.1530/EJE-21-0510.
2021
AOU San Luigi di Orbassano

Elhassan YS; Altieri B; Berhane S; Cosentini D; Calabrese A; Haissaguerre M; Kastelan D; Fragoso MCBV; Bertherat J; Al Ghuzlan A; Haak H; Boudina M; Canu L; Loli P; Sherlock M; Kimpel O; Laganà M; Sitch AJ; Kroiss M; Arlt W; Terzolo M; Berruti A; Deeks JJ; Libé R; Fassnacht M; Ronchi CL;

Contemporary Age-adjusted Incidence and Mortality Rates of Renal Cell Carcinoma: Analysis According to Gender, Race, Stage, Grade, and Histology. in European urology focus / Eur Urol Focus. 2021 May;7(3):644-652. doi: 10.1016/j.euf.2020.05.003. Epub 2020 May 23.
2021
AOU San Luigi di Orbassano

Palumbo C; Pecoraro A; Knipper S; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI; Palumbo C; Pecoraro A; Knipper S; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;

Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jul 5;28(8):593-604. doi: 10.1530/ERC-21-0123.
2021
AOU San Luigi di Orbassano

Gurizzan C; Zamparini M; Volante M; Tovazzi V; Amoroso V; Consoli F; Petrelli F; Grisanti S; Bossi P; Berruti A;

ENSAT registry-based randomized clinical trials for adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2021 Feb;184(2):R51-R59. doi: 10.1530/EJE-20-0800.
2021
AOU San Luigi di Orbassano

Crona J; Baudin E; Terzolo M; Chrisoulidou A; Angelousi A; Ronchi CL; Oliveira CL; Nieveen van Dijkum EJM; Ceccato F; Borson-Chazot F; Reimondo G; Tiberi GAM; Ettaieb H; Kiriakopoulos A; Canu L; Kastelan D; Osher E; Yiannakopoulou E; Arnaldi G; Assié G; Paiva I; Bourdeau I; Newell-Price J; Nowak KM; Romero MT; De Martino MC; Bugalho MJ; Sherlock M; Vantyghem MC; et alii...

Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy. in Endocrine / Endocrine. 2021 Apr;72(1):20-23. doi: 10.1007/s12020-020-02569-x. Epub 2021 Jan 5.
2021
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Laganà M; Ferrari VD; Volta AD; Sigala S; Terzolo M; Berruti A;

Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer. in Cancers / Cancers (Basel). 2020 Sep 14;12(9):2615. doi: 10.3390/cancers12092615.
2020
AOU San Luigi di Orbassano

Basile V; Puglisi S; Calabrese A; Pia A; Perotti P; Berruti A; Reimondo G; Terzolo M;

On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Oct;31(10):1415-1416. doi: 10.1016/j.annonc.2020.06.005. Epub 2020 Jun 18.
2020
ASL Asti
AOU San Luigi di Orbassano

Tucci M; Procopio G; Mucciarini C; Mosca A; Massari F; Masini C; Fratino L; Ermacora P; Fornarini G; Donini M; Ceresoli GL; Buti S; Bortolus R; Berruti A; Baldessari C; Zagonel V; Caffo O; Buttigliero C; Zucali P; Verri E;

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2020 Nov;31(11):1476-1490. doi: 10.1016/j.annonc.2020.08.2099. Epub 2020 Aug 27.
2020
AOU San Luigi di Orbassano

Fassnacht M; Assie G; Baudin E; Eisenhofer G; de la Fouchardiere C; Haak HR; de Krijger R; Porpiglia F; Terzolo M; Berruti A;

Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. in Journal of geriatric oncology / J Geriatr Oncol. 2020 May;11(4):718-723. doi: 10.1016/j.jgo.2019.06.005. Epub 2019 Jun 27.
2020
AOU San Luigi di Orbassano

Berruti A; Antonelli A; Saad F; Briganti A; Simeone C; Tian Z; Shariat SF; Rosiello G; Dzyuba-Negrean C; Pecoraro A; Knipper S; Palumbo C; Karakiewicz PI;

Treatment With 90Y/177Lu-DOTATOC in Patients With Metastatic Adrenocortical Carcinoma Expressing Somatostatin Receptors. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz091. doi: 10.1210/clinem/dgz091.
2020
AOU San Luigi di Orbassano

Grisanti S; Filice A; Basile V; Cosentini D; Rapa I; Albano D; Morandi A; Laganà M; Dalla Volta A; Bertagna F; Tiberio GMA; Volante M; Terzolo M; Versari A; Berruti A;

Patient frailty predicts worse perioperative outcomes and higher cost after radical cystectomy. in Surgical oncology / Surg Oncol. 2020 Mar;32:8-13. doi: 10.1016/j.suronc.2019.10.014. Epub 2019 Oct 25.
2020
AOU San Luigi di Orbassano

Berruti A; Antonelli A; Saad F; Briganti A; Simeone C; Tian Z; Shariat SF; Luzzago S; Deuker M; Rosiello G; Pecoraro A; Knipper S; Palumbo C; Karakiewicz PI;

Differences in short-term outcomes between open versus robot-assisted radical cystectomy in frail malnourished patients. in European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology / Eur J Surg Oncol. 2020 Jul;46(7):1347-1352. doi: 10.1016/j.ejso.2020.03.204. Epub 2020 Mar 14.
2020
AOU San Luigi di Orbassano

Palumbo C; Knipper S; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;

Bladder cancer incidence rates and trends in young adults aged 20-39 years. in Urologic oncology / Urol Oncol. 2020 Dec;38(12):934.e11-934.e19. doi: 10.1016/j.urolonc.2020.06.009. Epub 2020 Jul 9.
2020
AOU San Luigi di Orbassano

Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;

Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2020 Dec;18(6):e730-e738. doi: 10.1016/j.clgc.2020.05.009. Epub 2020 May 20.
2020
AOU San Luigi di Orbassano

Palumbo C; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Dzyuba-Negrean C; Shariat SF; Saad F; Simeone C; Berruti A; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI;

Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2020 Aug 1;105(8):dgaa293. doi: 10.1210/clinem/dgaa293.
2020
AOU San Luigi di Orbassano

Weigand I; Altieri B; Lacombe AMF; Basile V; Kircher S; Landwehr LS; Schreiner J; Zerbini MCN; Ronchi CL; Megerle F; Berruti A; Canu L; Volante M; Paiva I; Della Casa S; Sbiera S; Fassnacht M; Fragoso MCBV; Terzolo M; Kroiss M;

Renal cell carcinoma incidence rates and trends in young adults aged 20-39 years. in Cancer epidemiology / Cancer Epidemiol. 2020 Aug;67:101762. doi: 10.1016/j.canep.2020.101762. Epub 2020 Jun 22.
2020
AOU San Luigi di Orbassano

Palumbo C; Pecoraro A; Rosiello G; Luzzago S; Deuker M; Stolzenbach F; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;

Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells. in Cancers / Cancers (Basel). 2020 Apr 9;12(4):928. doi: 10.3390/cancers12040928.
2020
AOU San Luigi di Orbassano

Abate A; Rossini E; Bonini SA; Fragni M; Cosentini D; Tiberio GAM; Benetti D; Hantel C; Laganà M; Grisanti S; Terzolo M; Memo M; Berruti A; Sigala S;

2020
AOU San Luigi di Orbassano

Laganà M; Grisanti S; Cosentini D; Ferrari VD; Lazzari B; Ambrosini R; Sardini C; Volta AD; Palumbo C; Poliani PL; Terzolo M; Sigala S; Tiberio GAM; Berruti A;

Adrenocortical Carcinoma Xenograft in Zebrafish Embryos as a Model To Study the In Vivo Cytotoxicity of Abiraterone Acetate. in Endocrinology / Endocrinology. 2019 Nov 1;160(11):2620-2629. doi: 10.1210/en.2019-00152.
2019
AOU San Luigi di Orbassano

Gianoncelli A; Guarienti M; Fragni M; Bertuzzi M; Rossini E; Abate A; Basnet RM; Zizioli D; Bono F; Terzolo M; Memo M; Berruti A; Sigala S;

Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study. in European journal of endocrinology / Eur J Endocrinol. 2019 May 1;180(5):311-320. doi: 10.1530/EJE-19-0026.
2019
AOU San Luigi di Orbassano

Berruti A; Libè R; Laganà M; Ettaieb H; Sukkari MA; Bertherat J; Feelders RA; Grisanti S; Cartry J; Mazziotti G; Sigala S; Baudin E; Haak H; Habra MA; Terzolo M;

In vitro antitumor activity of progesterone in human adrenocortical carcinoma. in Endocrine / Endocrine. 2019 Mar;63(3):592-601. doi: 10.1007/s12020-018-1795-x. Epub 2018 Oct 26.
2019
AOU San Luigi di Orbassano

Fragni M; Fiorentini C; Rossini E; Fisogni S; Vezzoli S; Bonini SA; Dalmiglio C; Grisanti S; Tiberio GAM; Claps M; Cosentini D; Salvi V; Bosisio D; Terzolo M; Missale C; Facchetti F; Memo M; Berruti A; Sigala S;

Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence. in European journal of endocrinology / Eur J Endocrinol. 2019 Jun 1;180(6):387-396. doi: 10.1530/EJE-18-0923.
2019
AOU San Luigi di Orbassano

Calabrese A; Basile V; Puglisi S; Perotti P; Pia A; Saba L; Berchialla P; Porpiglia F; Veltri A; Volante M; Reimondo G; Berruti A; Terzolo M;

2019
ASL Asti
AOU San Luigi di Orbassano

Sigala S; Buttigliero C; Vittorio Scagliotti G; Bedussi F; Dalla Volta A; Pia A; Ferrari L; Tucci M; Roca E; Berruti A;

In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures(?). in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2019 Dec 1;498:110585. doi: 10.1016/j.mce.2019.110585. Epub 2019 Sep 16.
2019
AOU San Luigi di Orbassano

Fragni M; Palma Lopez LP; Rossini E; Abate A; Cosentini D; Salvi V; Vezzoli S; Poliani PL; Bosisio D; Hantel C; Tiberio GAM; Grisanti S; Memo M; Terzolo M; Berruti A; Sigala S;

Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. in European journal of endocrinology / Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
2019
AOU San Luigi di Orbassano

Cosentini D; Badalamenti G; Grisanti S; Basile V; Rapa I; Cerri S; Spallanzani A; Perotti P; Musso E; Laganà M; Ferrari VD; Luppi G; Dalla Volta A; Incorvaia L; Sigala S; Russo A; Volante M; Terzolo M; Berruti A;

2019
AOU San Luigi di Orbassano

Palumbo C; Pecoraro A; Knipper S; Rosiello G; Tian Z; Shariat SF; Simeone C; Briganti A; Saad F; Berruti A; Antonelli A; Karakiewicz PI;

2018
AOU San Luigi di Orbassano

Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M;

Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options. in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2018 Nov;18(11):1125-1133. doi: 10.1080/14737140.2018.1510325. Epub 2018
2018
AOU San Luigi di Orbassano

Puglisi S; Perotti P; Cosentini D; Roca E; Basile V; Berruti A; Terzolo M;

Palbociclib inhibits proliferation of human adrenocortical tumor cells. in Endocrine / Endocrine. 2018 Jan;59(1):213-217. doi: 10.1007/s12020-017-1270-0. Epub 2017 Mar 6.
2018
AOU San Luigi di Orbassano

Fiorentini C; Fragni M; Tiberio GAM; Galli D; Roca E; Salvi V; Bosisio D; Missale C; Terzolo M; Memo M; Berruti A; Sigala S; Fiorentini C; Fragni M; Tiberio GAM; Galli D; Roca E; Salvi V; Bosisio D; Missale C; Terzolo M; Memo M; Berruti A; Sigala S;

The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients. in Cancers / Cancers (Basel). 2018 Dec 24;11(1):18. doi: 10.3390/cancers11010018.
2018
AOU San Luigi di Orbassano

Campagna S; Sperlinga R; Milo A; Sannuto S; Acquafredda F; Saini A; Gonella S; Berruti A; Scagliotti GV; Tampellini M;

Immunotherapy failure in adrenocortical cancer: where next? in Endocrine connections / Endocr Connect. 2018 Dec;7(12):E5-E8. doi: 10.1530/EC-18-0398.
2018
AOU San Luigi di Orbassano

Cosentini D; Grisanti S; Dalla Volta A; Laganà M; Fiorentini C; Perotti P; Sigala S; Berruti A;

Detailed genomic characterization identifies high heterogeneity and histotype-specific genomic profiles in adrenocortical carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2018 Aug;31(8):1257-1269. doi: 10.1038/s41379-018-0042-6. Epub 2018 Mar 26.
2018
AOU San Luigi di Orbassano

Vatrano S; Volante M; Duregon E; Giorcelli J; Izzo S; Rapa I; Votta A; Germano A; Scagliotti G; Berruti A; Terzolo M; Papotti AM;

CYP11B1 has no role in mitotane action and metabolism in adrenocortical carcinoma cells. in PloS one / PLoS One. 2018 May 7;13(5):e0196931. doi: 10.1371/journal.pone.0196931. eCollection 2018.
2018
AOU San Luigi di Orbassano

Germano A; Saba L; De Francia S; Rapa I; Perotti P; Berruti A; Volante M; Terzolo M;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

Topoisomerase 2? and thymidylate synthase expression in adrenocortical cancer. in Endocrine-related cancer / Endocr Relat Cancer. 2017 Jul;24(7):319-327. doi: 10.1530/ERC-17-0095. Epub 2017 Apr 21.
2017
AOU San Luigi di Orbassano

Roca E; Berruti A; Sbiera S; Rapa I; Oneda E; Sperone P; Ronchi CL; Ferrari L; Grisanti S; Germano A; Zaggia B; Scagliotti GV; Fassnacht M; Volante M; Terzolo M; Papotti M;

2017
AOU San Luigi di Orbassano

Ferolla P; Brizzi MP; Meyer T; Mansoor W; Mazieres J; Do Cao C; Léna H; Berruti A; Damiano V; Buikhuisen W; Grønbæk H; Lombard-Bohas C; Grohé C; Minotti V; Tiseo M; De Castro J; Reed N; Gislimberti G; Singh N; Stankovic M; Öberg K; Baudin E;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.
2017
AO Ordine Mauriziano
AOU San Luigi di Orbassano

DI Maio M; Scagliotti GV; Aroasio E; Buttigliero C; Berruti A; Bertaglia V; Tucci M; Vignani F;

Management of patients with castration-resistant prostate cancer (CRPC): results of an Italian survey using the delphi method. in Tumori / Tumori. 2016 Oct 13;102(5):514-520. doi: 10.5301/tj.5000389. Epub 2015 Jun 30.
2016
AOU San Luigi di Orbassano

Vavassori V; Papotti M; Berruti A; Terrone C; Sciarra A;

Androgen deprivation modulates gene expression profile along prostate cancer progression. in Human pathology / Hum Pathol. 2016 Oct;56:81-8. doi: 10.1016/j.humpath.2016.06.004. Epub 2016 Jun 21.
2016
AOU San Luigi di Orbassano

Volante M; Tota D; Giorcelli J; Bollito E; Napoli F; Vatrano S; Buttigliero C; Molinaro L; Gontero P; Porpiglia F; Tucci M; Papotti M; Berruti A; Rapa I;

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer. in Future oncology (London, England) / Future Oncol. 2016 Feb;12(4):493-502. doi: 10.2217/fon.15.302. Epub 2016 Jan 18.
2016
AOU San Luigi di Orbassano

Veccia A; Caffo O; De Giorgi U; Di Lorenzo G; Ortega C; Scognamiglio F; Aieta M; Facchini G; Mansueto G; Mattioli R; Procopio G; Zagonel V; D'Angelo A; Spizzo G; Bortolus R; Donini M; Lo Re G; Massari F; Vicario G; Zucali PA; Alesini D; Bonetti A; Mucciarini C; Nicodemo M; Berruti A; Fratino L; Lodde M; Messina C; Perin A; et alii...

Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2016 Dec;101(12):4594-4602. doi: 10.1210/jc.2016-2414. Epub 2016 Sep 14.
2016
AOU San Luigi di Orbassano

Fiorentini C; Fragni M; Perego P; Vezzoli S; Bonini SA; Tortoreto M; Galli D; Claps M; Tiberio GA; Terzolo M; Missale C; Memo M; Procopio G; Zaffaroni N; Berruti A; Sigala S;

Does nephrectomy during radical adrenalectomy for stage II adrenocortical cancer affect patient outcome? in Journal of endocrinological investigation / J Endocrinol Invest. 2016 Apr;39(4):465-71. doi: 10.1007/s40618-015-0422-4. Epub 2015 Dec 22.
2016
AOU San Luigi di Orbassano

Scagliotti GV; Berruti A; Papotti M; Scarpa RM; Ardito A; Zaggia B; Daffara FC; Fiori C; Porpiglia F; Terzolo M;

The fat body mass increase after adjuvant androgen deprivation therapy is predictive of prostate cancer outcome. in Endocrine / Endocrine. 2015 Sep;50(1):223-30. doi: 10.1007/s12020-015-0525-x. Epub 2015 Jan 15.
2015
AOU San Luigi di Orbassano

Buttigliero C; Vana F; Bertaglia V; Vignani F; Fiori C; Osella G; Porpiglia F; Tucci M; Scagliotti GV; Berruti A;

Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. in Oncotarget / Oncotarget. 2015 May 20;6(14):12520-8. doi: 10.18632/oncotarget.3724.
2015
AOU San Luigi di Orbassano

Iuliani M; Pantano F; Buttigliero C; Fioramonti M; Bertaglia V; Vincenzi B; Zoccoli A; Ribelli G; Tucci M; Vignani F; Berruti A; Scagliotti GV; Tonini G; Santini D;

The prognostic role of baseline CEA and CA 19-9 values and their time-dependent variations in advanced colorectal cancer patients submitted to first-line therapy. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2015 Mar;36(3):1519-27. doi: 10.1007/s13277-014-2693-3. Epub 2014 Nov 6.
2015
AOU San Luigi di Orbassano

Tampellini M; Ottone A; Alabiso I; Baratelli C; Forti L; Berruti A; Aroasio E; Scagliotti GV;

RRM1 modulates mitotane activity in adrenal cancer cells interfering with its metabolization. in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2015 Feb 5;401:105-10. doi: 10.1016/j.mce.2014.11.027. Epub 2014 Dec 9.
2015
AOU San Luigi di Orbassano

Germano A; Rapa I; Volante M; De Francia S; Migliore C; Berruti A; Papotti M; Terzolo M;

Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation cases. in Human pathology / Hum Pathol. 2015 Dec;46(12):1799-807. doi: 10.1016/j.humpath.2015.08.012. Epub 2015 Sep 11.
2015
AOU San Luigi di Orbassano

Duregon E; Volante M; Bollito E; Goia M; Buttigliero C; Zaggia B; Berruti A; Scagliotti GV; Papotti M;

Alberta Breakthrough Pain Assessment Tool: A validation multicentre study in cancer patients with breakthrough pain. in European journal of pain (London, England) / Eur J Pain. 2015 Aug;19(7):881-8. doi: 10.1002/ejp.612. Epub 2014 Nov 5.
2015
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Scagliotti GV; Saini A; Tucci M; Rosato R; Giuliano PL; Ginosa I; Paoletti S; Laciura P; Berruti A; Campagna S; Sperlinga R;

Expression analysis of genes involved in DNA repair or synthesis in mixed neuroendocrine/nonneuroendocrine carcinomas. in Neuroendocrinology / Neuroendocrinology. 2015;101(2):151-60. doi: 10.1159/000375449. Epub 2015 Jan 29.
2015
AOU San Luigi di Orbassano

Volante M; Monica V; Birocco N; Brizzi MP; Busso S; Daniele L; La Rosa S; Righi L; Sapino A; Berruti A; Scagliotti GV; Papotti M;

Real-world study of everolimus in advanced progressive neuroendocrine tumors. in The oncologist / Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12.
2014
AOU San Luigi di Orbassano

Panzuto F; Rinzivillo M; Fazio N; de Braud F; Luppi G; Zatelli MC; Lugli F; Tomassetti P; Riccardi F; Nuzzo C; Brizzi MP; Faggiano A; Zaniboni A; Nobili E; Pastorelli D; Cascinu S; Merlano M; Chiara S; Antonuzzo L; Funaioli C; Spada F; Pusceddu S; Fontana A; Ambrosio MR; Cassano A; Campana D; Cartenì G; Appetecchia M; Berruti A; et alii...

Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines. in Molecular and cellular endocrinology / Mol Cell Endocrinol. 2014 Jan 25;382(1):1-7. doi: 10.1016/j.mce.2013.08.023. Epub 2013 Sep 7.
2014
AOU San Luigi di Orbassano

Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M; Germano A; Rapa I; Volante M; Lo Buono N; Carturan S; Berruti A; Terzolo M; Papotti M;

Pathologic complete response as a potential surrogate for the clinical outcome in patients with breast cancer after neoadjuvant therapy: a meta-regression of 29 randomized prospective studies. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2014 Dec 1;32(34):3883-91. doi: 10.1200/JCO.2014.55.2836. Epub 2014 Oct 27.
2014
AOU San Luigi di Orbassano

Berruti A; Amoroso V; Gallo F; Bertaglia V; Simoncini E; Pedersini R; Ferrari L; Bottini A; Bruzzi P; Sormani MP;

Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. in European urology / Eur Urol. 2014 Apr;65(4):832-8. doi: 10.1016/j.eururo.2013.11.006. Epub 2013 Nov 14.
2014
AOU San Luigi di Orbassano

Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; Kerkhofs T; Williams AR; Ardito A; Leboulleux S; Volante M; Deutschbein T; Feelders R; Ronchi C; Grisanti S; Gelderblom H; Porpiglia F; Papotti M; Hammer GD; Allolio B; Terzolo M; Berruti A; Fassnacht M; Haak H; Else T; Baudin E; Sperone P; Kroiss M; et alii...

Intermittent everolimus administration for malignant insulinoma. in Endocrinology, diabetes & metabolism case reports / Endocrinol Diabetes Metab Case Rep. 2014;2014:140047. doi: 10.1530/EDM-14-0047. Epub 2014 Sep 1.
2014
AOU San Luigi di Orbassano

Baratelli C; Brizzi MP; Tampellini M; Scagliotti GV; Priola A; Terzolo M; Pia A; Berruti A;

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection. in European journal of endocrinology / Eur J Endocrinol. 2013 Jul 29;169(3):263-70. doi: 10.1530/EJE-13-0242. Print 2013 Sep.
2013
AOU San Luigi di Orbassano

Terzolo M; Baudin AE; Ardito A; Kroiss M; Leboulleux S; Daffara F; Perotti P; Feelders RA; deVries JH; Zaggia B; De Francia S; Volante M; Haak HR; Allolio B; Al Ghuzlan A; Fassnacht M; Berruti A;

The reticulin algorithm for adrenocortical tumor diagnosis: a multicentric validation study on 245 unpublished cases. in The American journal of surgical pathology / Am J Surg Pathol. 2013 Sep;37(9):1433-40. doi: 10.1097/PAS.0b013e31828d387b.
2013
AOU San Luigi di Orbassano

Duregon E; Fassina A; Volante M; Nesi G; Santi R; Gatti G; Cappellesso R; Dalino Ciaramella P; Ventura L; Gambacorta M; Dei Tos AP; Loli P; Mannelli M; Mantero F; Berruti A; Terzolo M; Papotti M;

Metronomic chemotherapy may be active in heavily pre-treated patients with metastatic adreno-cortical carcinoma. in Journal of endocrinological investigation / J Endocrinol Invest. 2013 Mar;36(3):148-52. doi: 10.3275/8334. Epub 2012 Apr 5.
2013
AOU San Luigi di Orbassano

Ferrero A; Sperone P; Ardito A; Rossi G; Del Buono S; Priola AM; Bracarda S; Taberna E; Terzolo M; Berruti A;

Restless legs syndrome as a cause of sleep disturbances in cancer patients receiving chemotherapy. in Journal of pain and symptom management / J Pain Symptom Manage. 2013 Jul;46(1):56-64. doi: 10.1016/j.jpainsymman.2012.06.018. Epub 2012 Oct 3
2013
AOU San Luigi di Orbassano

Saini A; Berruti A; Ferini-Strambi L; Castronovo V; Rametti E; Giuliano PL; Ramassotto B; Picci RL; Negro M; Campagna S; Furlan PM; Ostacoli L;

Circadian variation of breakthrough pain in cancer patients. in European journal of pain (London, England) / Eur J Pain. 2013 Feb;17(2):264-70. doi: 10.1002/j.1532-2149.2012.00184.x. Epub 2012 Jun 19.
2013
AOU San Luigi di Orbassano

Saini A; Tucci M; Tampellini M; Maina D; Bouraouia K; Giuliano PL; Termine A; Castellano M; Campagna S; Laciura P; Berruti A;

Strategies for managing ACTH dependent mineralocorticoid excess induced by abiraterone. in Cancer treatment reviews / Cancer Treat Rev. 2013 Dec;39(8):966-73. doi: 10.1016/j.ctrv.2013.03.003. Epub 2013 Apr 10.
2013
AOU San Luigi di Orbassano

Pia A; Vignani F; Attard G; Tucci M; Bironzo P; Scagliotti G; Arlt W; Terzolo M; Berruti A;

2013
AOU San Luigi di Orbassano

Rapa I; Volante M; Migliore C; Farsetti A; Berruti A; Vittorio Scagliotti G; Giordano S; Papotti M;

Tumor staging but not grading is associated with adverse clinical outcome in neuroendocrine tumors of the appendix: a retrospective clinical pathologic analysis of 138 cases. in The American journal of surgical pathology / Am J Surg Pathol. 2013 Apr;37(4):606-12. doi: 10.1097/PAS.0b013e318275d1d7.
2013
AOU San Luigi di Orbassano

Volante M; Daniele L; Asioli S; Cassoni P; Comino A; Coverlizza S; De Giuli P; Fava C; Manini C; Berruti A; Papotti M;

Natural history of malignant bone disease in renal cancer: final results of an Italian bone metastasis survey. in PloS one / PLoS One. 2013 Dec 30;8(12):e83026. doi: 10.1371/journal.pone.0083026. eCollection 2013.
2013
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sabbatini R; Maiello E; Adamo V; Tanca FM; Fedeli SL; Badalamenti G; Russo A; Collovà E; Satolli MA; Silvestris N; Santoni M; Virzì V; Lanzetta G; Carteni G; Ottaviani D; Ortega C; Vincenzi B; Berardi R; Berruti A; Fontana A; Mazzara C; Barni S; Porta C; Ibrahim T; Procopio G; Santini D; Felici A; Cinieri S; Tonini G; et alii...

Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2012 Oct;23 Suppl 7:vii131-8. doi: 10.1093/annonc/mds231.
2012
AOU San Luigi di Orbassano

Berruti A; Baudin E; Gelderblom H; Haak HR; Porpiglia F; Fassnacht M; Pentheroudakis G;

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma. in European journal of endocrinology / Eur J Endocrinol. 2012 Mar;166(3):451-8. doi: 10.1530/EJE-11-0918. Epub 2011 Dec 21.
2012
AOU San Luigi di Orbassano

Berruti A; Sperone P; Ferrero A; Germano A; Ardito A; Priola AM; De Francia S; Volante M; Daffara F; Generali D; Leboulleux S; Perotti P; Baudin E; Papotti M; Terzolo M;

Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer. in Clinical cancer research : an official journal of the American Association for Cancer Research / Clin Cancer Res. 2012 Jun 15;18(12):3452-61. doi: 10.1158/1078-0432.CCR-11-2692. Epub 2012 Apr 30.
2012
AOU San Luigi di Orbassano

Volante M; Terzolo M; Fassnacht M; Rapa I; Germano A; Sbiera S; Daffara F; Sperone P; Scagliotti G; Allolio B; Papotti M; Berruti A;

Management of adjuvant mitotane therapy following resection of adrenal cancer. in Endocrine / Endocrine. 2012 Dec;42(3):521-5. doi: 10.1007/s12020-012-9719-7. Epub 2012 Jun 17.
2012
AOU San Luigi di Orbassano

Terzolo M; Ardito A; Zaggia B; Laino F; Germano A; De Francia S; Daffara F; Berruti A;

The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. in The oncologist / Oncologist. 2012;17(11):1430-8. doi: 10.1634/theoncologist.2012-0142. Epub 2012 Sep 6.
2012
AOU San Luigi di Orbassano

Tampellini M; Ottone A; Bellini E; Alabiso I; Baratelli C; Bitossi R; Brizzi MP; Ferrero A; Sperti E; Leone F; Miraglia S; Forti L; Bertona E; Ardissone F; Berruti A; Alabiso O; Aglietta M; Scagliotti GV;

Prognostic role of serum parathyroid hormone levels in advanced prostate cancer patients undergoing zoledronic acid administration. in The oncologist / Oncologist. 2012;17(5):645-52. doi: 10.1634/theoncologist.2011-0448. Epub 2012 Apr 20.
2012
AOU San Luigi di Orbassano

Berruti A; Cook R; Saad F; Buttigliero C; Lipton A; Tampellini M; Lee KA; Coleman RE; Smith MR;

Prevalence of complementary/alternative medicines (CAMs) in a cancer population in northern Italy receiving antineoplastic treatments and relationship with quality of life and psychometric features. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2011 Jun;20(5):683-90. doi: 10.1007/s11136-010-9795-1. Epub 2010 Nov 16.
2011
AOU San Luigi di Orbassano

Saini A; Berruti A; Capogna S; Negro M; Sguazzotti E; Picci RL; Campagna S; Dongiovanni V; Dogliotti L; Furlan PM; Ostacoli L;

Oncocytic adrenocortical tumors: diagnostic algorithm and mitochondrial DNA profile in 27 cases. in The American journal of surgical pathology / Am J Surg Pathol. 2011 Dec;35(12):1882-93. doi: 10.1097/PAS.0b013e31822da401.
2011
AOU San Luigi di Orbassano

Duregon E; Volante M; Cappia S; Cuccurullo A; Bisceglia M; Wong DD; Spagnolo DV; Szpak-Ulczok S; Bollito E; Daffara F; Berruti A; Terzolo M; Papotti M;

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2011 Apr;22(4):988-990. doi: 10.1093/annonc/mdr010. Epub 2011 Feb 14.
2011
AOU San Luigi di Orbassano

Bellini E; Pia A; Brizzi MP; Tampellini M; Torta M; Terzolo M; Dogliotti L; Berruti A;

The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2011 Apr;458(4):393-402. doi: 10.1007/s00428-011-1060-7. Epub 2011 Feb 23.
2011
AOU San Luigi di Orbassano

Volante M; Righi L; Berruti A; Rindi G; Papotti M;

Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2011 Apr;47(6):814-8. doi: 10.1016/j.ejca.2010.12.026. Epub 2011 Feb 18.
2011
AOU San Luigi di Orbassano

Guglielmelli T; Bringhen S; Rrodhe S; Gay F; Cavallo F; Berruti A; Montefusco V; Piro E; Benevolo G; Petrucci MT; Caravita T; Offidani M; Corradini P; Boccadoro M; Saglio G; Palumbo A;

Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. in The oncologist / Oncologist. 2011;16(9):1215-27. doi: 10.1634/theoncologist.2011-0098. Epub 2011 Aug 11.
2011
AOU San Luigi di Orbassano

Buttigliero C; Monagheddu C; Petroni P; Saini A; Dogliotti L; Ciccone G; Berruti A;

2011
AOU San Luigi di Orbassano

Berruti A; Generali D; Kaufmann M; Puztai L; Curigliano G; Aglietta M; Gianni L; Miller WR; Untch M; Sotiriou C; Daidone M; Conte P; Kennedy D; Damia G; Petronini P; Di Cosimo S; Bruzzi P; Dowsett M; Desmedt C; Mansel RE; Olivetti L; Tondini C; Sapino A; Fenaroli P; Tortora G; Thorne H; Bertolini F; Ferrozzi F; Danova M; et alii...

Intermediate endpoints of primary systemic therapy in breast cancer patients. in Journal of the National Cancer Institute. Monographs / J Natl Cancer Inst Monogr. 2011;2011(43):142-6. doi: 10.1093/jncimonographs/lgr036.
2011
AOU San Luigi di Orbassano

Berruti A; Generali D; Bertaglia V; Brizzi MP; Mele T; Dogliotti L; Bruzzi P; Bottini A;

Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2010 Oct;123(3):795-804. doi: 10.1007/s10549-010-1063-0. Epub 2010 Aug 3.
2010
AOU San Luigi di Orbassano

Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A;

Restless legs syndrome and its relationship with anxiety, depression, and quality of life in cancer patients undergoing chemotherapy. in Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation / Qual Life Res. 2010 May;19(4):531-7. doi: 10.1007/s11136-010-9614-8. Epub 2010 Feb 27.
2010
AOU San Luigi di Orbassano

Ostacoli L; Saini A; Ferini-Strambi L; Castronovo V; Sguazzotti E; Picci RL; Toje M; Gorzegno G; Capogna S; Dongiovanni V; Dogliotti L; Furlan PM; Berruti A;

Diagnostic accuracy and complication rate of CT-guided fine needle aspiration biopsy of lung lesions: a study based on the experience of the cytopathologist. in Acta radiologica (Stockholm, Sweden : 1987) / Acta Radiol. 2010 Jun;51(5):527-33. doi: 10.3109/02841851003691979.
2010
AOU San Luigi di Orbassano

Priola AM; Priola SM; Cataldi A; Di Franco M; Pazè F; Marci V; Berruti A;

Prognostic role of neuroendocrine differentiation in prostate cancer, putting together the pieces of the puzzle. in Open access journal of urology / Open Access J Urol. 2010 Jul 23;2:109-24. doi: 10.2147/rru.s6573.
2010
AOU San Luigi di Orbassano

Berruti A; Vignani F; Russo L; Bertaglia V; Tullio M; Tucci M; Poggio M; Dogliotti L;

2009
AOU San Luigi di Orbassano

Brizzi MP; Berruti A; Ferrero A; Milanesi E; Volante M; Castiglione F; Birocco N; Bombaci S; Perroni D; Ferretti B; Alabiso O; Ciuffreda L; Bertetto O; Papotti M; Dogliotti L;

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2009;12(1):94-9. doi: 10.1038/pcan.2008.10. Epub 2008 Mar 11.
2009
AOU San Luigi di Orbassano

Tucci M; Mosca A; Lamanna G; Porpiglia F; Terzolo M; Vana F; Cracco C; Russo L; Gorzegno G; Tampellini M; Torta M; Reimondo G; Poggio M; Scarpa RM; Angeli A; Dogliotti L; Berruti A;

2008
AOU San Luigi di Orbassano

Bitossi R; Sculli CM; Tampellini M; Alabiso I; Brizzi MP; Ferrero A; Ottone A; Bellini E; Gorzegno G; Berruti A; Dogliotti L;

Emerging drugs for adrenocortical carcinoma. in Expert opinion on emerging drugs / Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497.
2008
AOU San Luigi di Orbassano

Berruti A; Ferrero A; Sperone P; Daffara F; Reimondo G; Papotti M; Dogliotti L; Angeli A; Terzolo M;

Presurgical systemic treatment of nonmetastatic breast cancer: facts and open questions. in The oncologist / Oncologist. 2008 Nov;13(11):1137-48. doi: 10.1634/theoncologist.2008-0162. Epub 2008 Nov 7.
2008
AOU San Luigi di Orbassano

Berruti A; Brizzi MP; Generali D; Ardine M; Dogliotti L; Bruzzi P; Bottini A;

Pathological and molecular features of adrenocortical carcinoma: an update. in Journal of clinical pathology / J Clin Pathol. 2008 Jul;61(7):787-93. doi: 10.1136/jcp.2007.050625. Epub 2008 Apr 22.
2008
AOU San Luigi di Orbassano

Volante M; Buttigliero C; Greco E; Berruti A; Papotti M;

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly. in Endocrine-related cancer / Endocr Relat Cancer. 2008 Dec;15(4):1043-53. doi: 10.1677/ERC-08-0103. Epub 2008 Sep 29.
2008
AOU San Luigi di Orbassano

Daffara F; De Francia S; Reimondo G; Zaggia B; Aroasio E; Porpiglia F; Volante M; Termine A; Di Carlo F; Dogliotti L; Angeli A; Berruti A; Terzolo M;

Development and validation of a patient-physician relationship index in the advanced cancer setting. in Tumori / Tumori. 2007 Sep-Oct;93(5):485-90. doi: 10.1177/030089160709300513.
2007
AOU San Luigi di Orbassano

Ostacoli L; Costantini M; Beccaro M; Dellai M; Gorzegno G; Picci RL; Sguazzotti E; Berruti A; Torta R; Furlan PM;

Chromogranin A expression in patients with hormone naïve prostate cancer predicts the development of hormone refractory disease. in The Journal of urology / J Urol. 2007 Sep;178(3 Pt 1):838-43; quiz 1129. doi: 10.1016/j.juro.2007.05.018. Epub 2007 Jul 16.
2007
AOU San Luigi di Orbassano

Berruti A; Mosca A; Porpiglia F; Bollito E; Tucci M; Vana F; Cracco C; Torta M; Russo L; Cappia S; Saini A; Angeli A; Papotti M; Scarpa RM; Dogliotti L;

Thrombotic thrombocytopenic purpura in advanced prostate cancer: case report and published work review. in International journal of urology : official journal of the Japanese Urological Association / Int J Urol. 2007 Feb;14(2):150-2. doi: 10.1111/j.1442-2042.2006.01644.x.
2007
AOU San Luigi di Orbassano

Caramello V; Dovio A; Caraci P; Berruti A; Angeli A;

A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Jun 6;837(1-2):69-75. doi: 10.1016/j.jchromb.200
2006
AOU San Luigi di Orbassano

De Francia S; Pirro E; Zappia F; De Martino F; Sprio AE; Daffara F; Terzolo M; Berruti A; Di Carlo F; Ghezzo F;

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane. in Journal of endocrinological investigation / J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148.
2006
AOU San Luigi di Orbassano

Sperone P; Berruti A; Gorzegno G; Paccotti P; Terzolo M; Porpiglia F; Angeli A; Dogliotti L;

The role of haemoglobin level in predicting the response to first-line chemotherapy in advanced colorectal cancer patients. in British journal of cancer / Br J Cancer. 2006 Jul 3;95(1):13-20. doi: 10.1038/sj.bjc.6603204. Epub 2006 Jun 13.
2006
AOU San Luigi di Orbassano

Tampellini M; Saini A; Alabiso I; Bitossi R; Brizzi MP; Sculli CM; Berruti A; Gorzegno G; Magnino A; Sperti E; Miraglia S; Forti L; Alabiso O; Aglietta M; Harris A; Dogliotti L;

Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation. in The Lancet. Oncology / Lancet Oncol. 2006 Feb;7(2):186-7. doi: 10.1016/S1470-2045(06)70582-4.
2006
AOU San Luigi di Orbassano

Saini A; Berruti A; Sperone P; Bitossi R; Tampellini M; Dogliotti L; Gorzegno G;

Reassessing the current TNM lymph node staging for renal cell carcinoma. in European urology / Eur Urol. 2006 Feb;49(2):324-31. doi: 10.1016/j.eururo.2005.11.014. Epub 2005 Dec 20.
2006
AOU San Luigi di Orbassano

Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR;

Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas. in Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc / Mod Pathol. 2006 Dec;19(12):1563-9. doi: 10.1038/modpathol.3800683. Epub 2006 Sep 15.
2006
AOU San Luigi di Orbassano

Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M;

Prognostic significance of changes in CA 15-3 serum levels during chemotherapy in metastatic breast cancer patients. in Breast cancer research and treatment / Breast Cancer Res Treat. 2006 Aug;98(3):241-8. doi: 10.1007/s10549-005-9155-y. Epub 2006 May 3.
2006
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Bitossi R; Gorzegno G; Alabiso I; Bottini A; Farris A; Donadio M; Sarobba MG; Manzin E; Durando A; Defabiani E; De Matteis A; Ardine M; Castiglione F; Danese S; Bertone E; Alabiso O; Massobrio M; Dogliotti L;

Stage IB malignant thymoma in a Lynch syndrome patient with multiple cancers: response to incidental administration of oxaliplatin and 5-fluorouracil. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2006 Aug;18(4):433-6. doi: 10.1179/joc.2006.18.4.433.
2006
AOU San Luigi di Orbassano

Tampellini M; Alabiso I; Sculli CM; Barberis M; Giachino D; Berruti A; Dogliotti L;

Predictive factors for skeletal complications in hormone-refractory prostate cancer patients with metastatic bone disease. in British journal of cancer / Br J Cancer. 2005 Sep 19;93(6):633-8. doi: 10.1038/sj.bjc.6602767.
2005
AOU San Luigi di Orbassano

Berruti A; Tucci M; Mosca A; Tarabuzzi R; Gorzegno G; Terrone C; Vana F; Lamanna G; Tampellini M; Porpiglia F; Angeli A; Scarpa RM; Dogliotti L;

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial. in Endocrine-related cancer / Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025.
2005
AOU San Luigi di Orbassano

Berruti A; Terzolo M; Sperone P; Pia A; Della Casa S; Gross DJ; Carnaghi C; Casali P; Porpiglia F; Mantero F; Reimondo G; Angeli A; Dogliotti L;

Feasibility of 21-day continuous infusion of epirubicin in hormone-refractory prostate cancer patients. in Anticancer research / Anticancer Res. 2005 Nov-Dec;25(6C):4475-9.
2005
AOU San Luigi di Orbassano

Berruti A; Mosca A; Bitossi R; Gorzegno G; Guercio S; Poggio M; Tampellini M; Porpiglia F; Ostellino O; Scarpa RM; Dogliotti L;

2005
AOU San Luigi di Orbassano

Bottini A; Berruti A; Brizzi MP; Bersiga A; Generali D; Allevi G; Aguggini S; Bolsi G; Bonardi S; Tondelli B; Vana F; Tampellini M; Alquati P; Dogliotti L;

2005
AOU San Luigi di Orbassano

Berruti A; Fara E; Tucci M; Tarabuzzi R; Mosca A; Terrone C; Gorzegno G; Fasolis G; Tampellini M; Porpiglia F; De Stefanis M; Fontana D; Bertetto O; Dogliotti L;

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naive metastatic breast cancer patients. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2005 Jan;41(2):249-55. doi: 10.1016/j.ejca.2004.07.003.
2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Bottini A; Bonardi S; Donadio M; Nigro C; Bertetto O; Danese S; Bertone E; Sarobba MG; Farris A; Katsaros D; Castiglione F; Volpe T; Lattuada S; Mancarella S; Dogliotti L;

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines. in British journal of cancer / Br J Cancer. 2005 Feb 28;92(4):634-8. doi: 10.1038/sj.bjc.6602335.
2005
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Generali D; Milani M; Katsaros D; Rigault de la Longrais IA; Bellino R; Donadio M; Ardine M; Bertetto O; Danese S; Sarobba MG; Farris A; Lorusso V; Dogliotti L;

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects. in Journal of endocrinological investigation / J Endocrinol Invest. 2005;28(11 Suppl International):141-5.
2005
AOU San Luigi di Orbassano

Mosca A; Berruti A; Russo L; Torta M; Dogliotti L;

Somatostatin receptors: from basic science to clinical approach. Unlabeled somatostatin analogues-1: Prostate cancer. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2004 Feb;36 Suppl 1:S60-7. doi: 10.1016/j.dld.2003.11.021.
2004
AOU San Luigi di Orbassano

Mosca A; Dogliotti L; Berruti A; Lamberts SW; Hofland LJ;

Management of neuroendocrine differentiated breast carcinoma. in Breast (Edinburgh, Scotland) / Breast. 2004 Dec;13(6):527-9. doi: 10.1016/j.breast.2004.06.007.
2004
AOU San Luigi di Orbassano

Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L;

Metabolic effects of single-dose pamidronate administration in prostate cancer patients with bone metastases. in The International journal of biological markers / Int J Biol Markers. 2002 Oct-Dec;17(4):244-52. doi: 10.5301/jbm.2008.2194.
2002
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Tucci M; Tarabuzzi R; Guercio S; Torta M; Tampellini M; Dovio A; Poggio M; Scarpa RM; Angeli A;

Time to progression in metastatic breast cancer patients treated with epirubicin is not improved by the addition of either cisplatin or lonidamine: final results of a phase III study with a factorial design. in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2002 Oct 15;20(20):4150-9. doi: 10.1200/JCO.2002.08.012.
2002
AOU San Luigi di Orbassano

Berruti A; Bitossi R; Gorzegno G; Bottini A; Alquati P; De Matteis A; Nuzzo F; Giardina G; Danese S; De Lena M; Lorusso V; Farris A; Sarobba MG; DeFabiani E; Bonazzi G; Castiglione F; Bumma C; Moro G; Bruzzi P; Dogliotti L;

2002
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Terrone C; Cerutti S; Isaia G; Tarabuzzi R; Reimondo G; Mari M; Ardissone P; De Luca S; Fasolis G; Fontana D; Rossetti SR; Angeli A;

Background to and management of treatment-related bone loss in prostate cancer. in Drugs & aging / Drugs Aging. 2002;19(12):899-910. doi: 10.2165/00002512-200219120-00002.
2002
AOU San Luigi di Orbassano

Berruti A; Tucci M; Terrone C; Gorzegno G; Scarpa RM; Angeli A; Dogliotti L;

Independent factors predict supranormal CA 15-3 serum levels in advanced breast cancer patients at first disease relapse. in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine / Tumour Biol. 2001 Nov-Dec;22(6):367-73. doi: 10.1159/000050639.
2001
AOU San Luigi di Orbassano

Tampellini M; Berruti A; Gorzegno G; Bitossi R; Bottini A; Durando A; De Matteis A; Farris A; Donadio M; De Fabiani E; Manzin E; Arese P; Sarobba MG; Castiglione F; Moro G; Bonazzi G; Nuzzo F; Massobrio M; Dogliotti L;

2001
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Tarabuzzi R; Torta M; Mari M; Gorzegno G; Fontana D; Angeli A;

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Bitossi R; Fasolis G; Gorzegno G; Bellina M; Torta M; Porpiglia F; Fontana D; Angeli A;

Circulating neuroendocrine markers in patients with prostate carcinoma. in Cancer / Cancer. 2000 Jun 1;88(11):2590-7. doi: 10.1002/1097-0142(20000601)88:11<2590::aid-cncr23>3.0.co;2-d.
2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Mosca A; Bellina M; Mari M; Torta M; Tarabuzzi R; Bollito E; Fontana D; Angeli A;

2000
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Osella G; Cerutti S; Reimondo G; Martino A; Gorzegno G; Catolla R; Angeli A;

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Fasolis G; Mosca A; Tarabuzzi R; Torta M; Mari M; Fontana D; Angeli A;

1999
AOU San Luigi di Orbassano

Berruti A; Dogliotti L; Gorzegno G; Torta M; Tampellini M; Tucci M; Cerutti S; Frezet MM; Stivanello M; Sacchetto G; Angeli A;

Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 1998;41(4):333-8. doi: 10.1007/s002800050747.
1998
AOU San Luigi di Orbassano

Dogliotti L; Danese S; Berruti A; Zola P; Buniva T; Bottini A; Richiardi G; Moro G; Farris A; Baù MG; Porcile G;

Pamidronate administration improves the secondary hyperparathyroidism due to "Bone Hunger Syndrome" in a patient with osteoblastic metastases from prostate cancer. in The Prostate / Prostate. 1997 Dec 1;33(4):252-5. doi: 10.1002/(sici)1097-0045(19971201)33:4<252::aid-pros5>3.0.co;2
1997
AOU San Luigi di Orbassano

Berruti A; Sperone P; Fasolis G; Torta M; Fontana D; Dogliotti L; Angeli A;

Biochemical picture of bone metabolism in breast cancer patients with bone metastases. in Anticancer research / Anticancer Res. 1995 Nov-Dec;15(6B):2871-5.
1995
AOU San Luigi di Orbassano

Berruti A; Torta M; Piovesan A; Raucci CA; Orlandi F; Panero A; Dogliotti L; Angeli A;

Cytotoxic chemotherapy for adrenocortical carcinoma. in Minerva endocrinologica / Minerva Endocrinol. 1995 Mar;20(1):105-9.
1995
AOU San Luigi di Orbassano

Dogliotti L; Berruti A; Pia A; Paccotti P; Alì A; Angeli A;

Acute myeloblastic leukemia associated with mediastinal nonseminomatous germ cell tumors. Report on two cases. in Tumori / Tumori. 1995 Jul-Aug;81(4):299-301. doi: 10.1177/030089169508100417.
1995
AOU San Luigi di Orbassano

Berruti A; Pazè E; Fara E; Gorzegno G; Dogliotti L;

1995
AOU San Luigi di Orbassano

Berruti A; Gerbino A; Faggiuolo R; Rovero E; Dogliotti L;

Combination chemotherapy with carboplatin and methotrexate in the treatment of advanced urothelial carcinoma. A phase II study. in American journal of clinical oncology / Am J Clin Oncol. 1995 Feb;18(1):78-82. doi: 10.1097/00000421-199502000-00017.
1995
AOU San Luigi di Orbassano

Dogliotti L; Bertetto O; Berruti A; Clerico M; Fanchini L; Sicora W; Faggiuolo R;

Serum levels of carboxyterminal propeptide of type I procollagen in cancer patients with osteoblastic and osteolytic bone metastases. in The International journal of biological markers / Int J Biol Markers. 1994 Oct-Dec;9(4):243-6. doi: 10.1177/172460089400900407.
1994
AOU San Luigi di Orbassano

Piovesan A; Berruti A; Osella G; Raucci CA; Torta M; Dogliotti L; Angeli A;

1993
AOU San Luigi di Orbassano

Berruti A; Osella G; Raucci CA; Roncari A; Dogliotti L;

1992
AOU San Luigi di Orbassano

Berruti A; Gorzegno G; Vitetta G; Tampellini M; Dogliotti L;

Three years' experience with tropisetron in the control of nausea and vomiting in cisplatin-treated patients. in Drugs / Drugs. 1992;43 Suppl 3:6-10. doi: 10.2165/00003495-199200433-00004.
1992
AOU San Luigi di Orbassano

Dogliotti L; Antonacci RA; Pazè E; Ortega C; Berruti A; Faggiuolo R;